OD36   Click here for help

GtoPdb Ligand ID: 10406

PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: OD36-induced inhibition of RIPK2 produces anti-inflammatory activity in animal models of inflammatory bowel conditions [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 0
Topological polar surface area 60.68
Molecular weight 330.09
XLogP 3.19
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1cc2OCCOCCNc3nc4c(c(c1)c2)cnn4cc3
Isomeric SMILES Clc1cc2OCCOCCNc3nc4c(c(c1)c2)cnn4cc3
InChI InChI=1S/C16H15ClN4O2/c17-12-7-11-8-13(9-12)23-6-5-22-4-2-18-15-1-3-21-16(20-15)14(11)10-19-21/h1,3,7-10H,2,4-6H2,(H,18,20)
InChI Key KTSDBMVHAKWDRK-UHFFFAOYSA-N
Bioactivity Comments
In a kinase screening panel of 366 kinases, 100 nM OD36 inhibited several kinases by >50% (RIPK2 97%, ALK2 95%, SIK2 94%, ACVR2B 90%, ACVRL1 88%, ZAK 70%, TGFBR2 68%, DDR2 59%, FYN 59%, CDK8/cyclin C 57% [1]. The inhibition profile of OD36 differs from that of gefitinib (inhibits RIPK2 by 96% at 1μM), which facilitates idenification of RIPK2-mediated effects from those caused by inhibition of off-target kinases.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
receptor interacting serine/threonine kinase 2 Hs Inhibitor Inhibition 8.3 pIC50 - 1
pIC50 8.3 (IC50 5.3x10-9 M) [1]